High Strength Bone Extract
Contents: 60 tablets
Calcitite Hi-Strength is a well-rounded calcium supplement designed to be taken on an ongoing basis to maintain optimal bone mineral density and prevent osteoporosis. This formula contains easy-to-absorb hydroxyapatite bone extract and other essential cofactors that may assist in maintaining peak bone mass. The combination of calcium, magnesium, phosphorus, boron, vitamin D and vitamin K may assist in the prevention of osteoporosis and may be particularly beneficial for women, as their calcium requirements increase during pregnancy and after menopause.
Each tablet contains:
Microcrystalline hydroxyapatite 1000 mg
Equivalent to calcium: 255 mg
Equivalent to phosphorus: 120 mg
Calcium hydrogen phosphate 474.5 mg
Equivalent to calcium: 111.5 mg
Vitamin D3 (cholecalciferol) 333.33 IU
Boron 1 mg
Vitamin K1 27 µg [micrograms]
Directions: Adults: Take 1 tablet three times per day with food, or as directed by your healthcare professional.
• May assist in the prevention of osteoporosis: Microcrystalline hydroxyapatite is a comprehensive whole bone concentrate that delivers calcium, magnesium, and a full spectrum of trace minerals (e.g. boron, silica, zinc), in their natural ratios. It also delivers organic factors such as collagen protein, bone derived growth factors, glycosaminoglycans and amino acids which have been shown to positively impact bone density. This formula also contains vitamin D, which facilitates the active absorption of calcium in the intestine by stimulating the synthesis of calcium binding protein (calbindin), and vitamin K, which assists in the function of proteins important for bone building.
• Highly absorbable calcium: Bioavailability of calcium supplements varies depending on the form of calcium used, therefore it is important to select forms of calcium that have proven bioavailability. Microcrystalline hydroxyapatite has consistently shown superiority over other forms of calcium supplementation. Prevention of osteoporosis through slowing of postmenopausal bone loss has been found to be achieved more significantly with hydroxyapatite than with calcium carbonate. In a two year study involving 60 post-menopausal women, only the group given hydroxyapatite maintained bone mineral density, while other groups encountered a significant reduction in bone mineral density.